doi:10.1016/j.xcrm.2020.100185engVierboom, M.P.M.Dijkman, K.Sombroek, C.C.Hofman, S.O.Boot, C.Vervenne, R.A.W.Haanstra, K.G.van der Sande, M.van Emst, L.Domínguez-Andrés, J.Moorlag, S.J.C.F.M.Kocken, C.H.M.Thole, J.Rodríguez, E.Puentes, E.Martens, J.H.A.van Crevel, R.Netea, M.G.Aguilo, N.Martin, C.Verreck, F.A.W.Stronger induction of trained immunity by mucosal BCG or MTBVAC vaccination compared to standard intradermal vaccinationART-2021-123269Vierboom et al. demonstrate the induction of trained immunity in blood and bone marrow monocytes after vaccination with live attenuated TB vaccines in nonhuman primates. Mucosal respiratory delivery of BCG or MTBVAC induces trained immunity more efficiently compared to standard intradermal vaccination.2021http://zaguan.unizar.es/record/9974910.1016/j.xcrm.2020.100185http://zaguan.unizar.es/record/99749oai:zaguan.unizar.es:99749info:eu-repo/grantAgreement/EC/H2020/643381/EU/TBVAC2020; Advancing novel and promising TB vaccine candidates from discovery to preclinical and early clinical development/TBVAC2020This project has received funding from the European Union’s Horizon 2020 research and innovation program under grant agreement No H2020 643381-TBVAC2020info:eu-repo/grantAgreement/EC/H2020/730964/EU/European Vaccine Research and Development Infrastructure/TRANSVAC2This project has received funding from the European Union’s Horizon 2020 research and innovation program under grant agreement No H2020 730964-TRANSVAC2Cell reports medicine 2, 1 (2021), 100185 [20 pp]by-nc-ndhttp://creativecommons.org/licenses/by-nc-nd/3.0/es/info:eu-repo/semantics/openAccess